Precision Medicine Market to Surge to USD 365.5 Bn by 2033 – Ameco Research Forecasts 15.8% CAGR

DALLAS, Ore. - Aug. 8, 2025 - PRLog -- Ameco Research has unveiled its comprehensive Precision Medicine Market Report, delivering in-depth Market Analysis, strategic insights, and robust forecasts. Global Precision Medicine Market Size was valued at USD 98.3 Billion in 2024 and is projected to reach USD 365.5 Billion by 2033, with strong compound annual growth rate (CAGR) of 15.8% over forecast period.

Precision Medicine Market Statistics

• 2024 Market Size: USD 98.3 Billion
• 2033 Forecast: USD 365.5 Billion → signalling robust Market Growth at 15.8% CAGR between 2025–2033
• Dominant Technology: Gene sequencing led due to declining sequencing costs and rising demand in oncology and rare disease diagnostics
• Therapeutics Application: Oncology, cell & gene therapy, and inhibitor drugs dominate Market Share, reflecting rising personalized treatment adoption
• Leading End‑User: Hospitals and clinical laboratories account for largest revenue share.

Drivers & Emerging Market Trends

• Technological Advancements: Cutting-edge technologies like bioinformatics, big data analytics, and AI-based companion diagnostics are accelerating precision medicine revolution.
• Personalized Therapeutics Drive Growth: Increased demand for tailored treatments—especially in oncology and rare diseases—fuels both market growth and market share of targeted therapies such as kinase inhibitors and monoclonal antibodies.
• Genomic Adoption & Cost Reduction: Proliferation of next‑generation sequencing (NGS) and expanding access to genetic testing are driving expanded adoption globally.
• Government Initiatives & R&D Investment: Programs like U.S. "All of Us" initiative, UK's 100,000 Genomes Project, and China's Precision Medicine Initiative are catalyzing market acceleration.

Segmentation Insights

• By Type: Dominated by inhibitor drugs, monoclonal antibodies, and cell & gene therapies, with inhibitors capturing majority of revenue through 2024.
• By Technology: Gene sequencing leads, followed by companion diagnostics, bioinformatics, and big data analytics—each supporting market trends such as personalized diagnostics and targeted treatment development.
• By Application: Therapeutics—mainly oncology and immunology treatments—dominate. Genetic testing and diagnostics continue growth as direct-to-consumer and clinical sequencing expand.

Precision Medicine Market Competitive Landscape

Major players profiled in Precision Medicine Market Report include

• 23andMe
• NeoDiagnostix
• Siemens
• Quest Diagnostics
• QIAGEN
• Janssen
• Illumina
• GE Healthcare
• Abbott
• Myriad Genetics
• Medtronic

✅ Why This Report Matters

Ameco Research's Precision Medicine Market Report (https://n9.cl/2uh9b) delivers:

• Deep insights into market size, share, segmentation, and projected trends
• Strategic visibility into key market trends such as genomics, AI, and personalized therapeutics
• Actionable guidance for stakeholders—hospitals, diagnostics labs, pharma/biotech firms, and investors—to strategize around next-gen healthcare delivery

Download your complimentary sample report (https://n9.cl/gcrvpj) today to unlock comprehensive insights into Precision Medicine Market Size.